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INTRODUCTION 
Budd-Chiari syndrome is defined as hepatic venous outflow 
tract obstruction regardless of the level of the obstruction (any-
where between the small hepatic veins to the junction of the infe-
rior vena cava and right atrium) or the cause of obstruction.1 It is 
frequently associated with hepatomegaly, abdominal pain, ascites 
and hepatic dysfunction, and patients with Budd-Chiari syndrome 
often demonstrate one or more risk factors, including an underly-
ing hypercoagulable state, vascular injury and stasis, venous ob-
struction by neoplasm or cirrhosis, amebic abscess, sarcoidosis 
etc. Hypercoagulable states include oral contraceptive use, an-
tiphospholipid antibody syndrome, myeloproliferative diseases, 
paroxysmal nocturnal hemoglobinuria, factor V Leiden mutation, 
prothrombin gene G20210A mutation, and deficiencies of protein 
C, protein S, or antithrombin III. 
 Although marked congestion and fibrosis are the common fea-
tures of this condition, the histopathological features of Budd-Chi-
ari syndrome are actually very heterogeneous depending on the 
type of vascular occlusion present, its severity and the duration.2 
Obstruction of all three hepatic veins may initially present with ful-
minant hepatic failure, while involvement of one or two hepatic 
veins may be associated with only hepatomegaly and mild or tran-
sient liver test abnormalities. Portal vein obstruction is commonly 
seen in severe cases of Budd-Chiari syndrome.2,3 A case of Budd-
Chiari syndrome with multiple large regenerative nodules is de-
scribed, and the histopathological features discussed. 
CASE
A 31-year old male patient was referred to the clinic for further 
evaluation of a suspected right hepatic vein obstruction. He had 
been previously healthy without prior medico-surgical illnesses, 
and visited the local clinic complaining of abdominal discomfort 
and poor oral intake. Computed tomography (CT) showed hepato-
megaly with caudate lobe hypertrophy, ascites and occlusion of 
the right hepatic vein, suggestive of Budd-Chiari syndrome. Labo-
ratory evaluation on admission demonstrated elevated liver en-
zymes (AST 130 IU/L, ALT 108 IU/L, total bilirubin 2.2 mg/dL, di-
rect bilirubin 1.3 mg/dL, γ-GT 74 IU/L) and thrombocytopenia 
(106,000/μl). In addition, positivity for antinuclear antibody (ANA; 
1:640, speckled pattern), anti-DNA (454.5 AU/mL; reference 
range: <92.6 AU/mL), anti-cardiolipin IgG (21.5 GPL U/mL; refer-
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ence range: <10 GPL U/mL), anti-RNP (43.5 AU/mL; reference 
range: <20 AU/mL), anti-SS-A/Ro (148.9 AU/mL; reference range: 
<20 AU/mL) and anti-SS-B/La (86.2 AU/mL; reference range: <20 
AU/mL), and decreased protein S (38%; reference range: 
62~154%) were noted. Lupus anticoagulant screening test was 
positive.
Under the impression of Budd-Chiari syndrome, antiphospholip-
id syndrome and Sjogren’s syndrome, he underwent hepariniza-
tion, and a week later a balloonoplasty was performed for the 
right hepatic vein. However, Doppler ultrasonography revealed 
persistent thrombosis and occlusion of the right hepatic vein. Stent 
insertion was performed 5 days later, with a subsequent decrease 
in pressure gradient and an improvement in his liver function tests. 
The patient underwent coumadinization with conservative care. 
Two months later, he was re-admitted to hospital for recurrent as-
cites and occlusion of the right hepatic vein stent. Balloon dilata-
tion of the stent was attempted, but a follow-up venogram dem-
onstrated re-occlusion. Transjugular intrahepatic portosystemic 
shunt (TIPS) was performed two weeks later, after which the pa-
tient was followed up regularly. A year later, follow up magnetic 
resonance imaging (MRI) revealed obstruction of the branches of 
the right hepatic vein branches, ascites, hepatosplenomegaly, and 
also multiple hypervascular nodules in both lobes of the liver, 
which were hyperintense on T1-weighted images and iso- to hy-
pointense on T2-weighted images. TIPS ballooning was per-
formed, and two weeks later the patient received a living donor 
liver transplantation. 
PATHOLOGIC FINDINGS
The explanted liver weighed 1,950 g and measured 26.0 × 19.5 
× 12 cm. The external surface revealed protruding nodules mea-
suring up to 2.0 × 1.7 cm at segment 5 (Fig. 1). A previously in-
serted stent was present in the right hepatic vein. On serial sec-
tions, multiple randomly distributed well-demarcated yellowish-
brown solid nodules were seen, the largest one measuring up to 
3.2 × 2.5 × 2.3 cm in diameter. At least 15 nodules measuring 
larger than 0.5cm in diameter were identified grossly, and count-
less smaller nodules (0.1-0.5 cm) were scattered randomly in the 
right and left lobes, with relatively sparing of the caudate lobe 
(segment 1). The nodules had bulging cut surfaces, and some of 
the larger nodules contained irregular shaped fibrous scars, some-
what resembling focal nodular hyperplasia (FNH). The remaining 
hepatic parenchyme showed ill-defined patchy areas of congestion 
in the right lobe and the caudate lobe. There was no definite mac-
roscopic evidence of hepatic vein or portal vein occlusion. 
On microscopic evaluation, large and medium-sized small he-
Figure 1. Macroscopic findings of the explanted liver. (A) Bulging nodules measuring up to 2.0 × 1.7 cm are seen. (B) Consecutive serial sections dem-
onstrate countless multiple randomly distributed well-demarcated yellowish-brown nodules measuring up to 3.2 × 2.5 × 2.3 cm in diameter (arrow-
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Figure 2. (A) A large hepatic vein demonstrating marked intimal thickening. Marked hemorrhage is seen surrounding the hepatic vein. (B) A recent 
occlusion is seen in a hepatic vein, surrounded by hepatocyte dropout in the centrilobular zone. The periportal hepatocytes are relatively spared (PT: 
portal tract, HV: hepatic vein). (C) Marked sinusoidal dilatation and congestion, with atrophy of hepatocytes is seen in the lower half of the photo-
graph. (D) Venocentric (reverse-lobulation) cirrhosis. A portal tract at the center of a cirrhotic nodule. (E) A small portal vein shows organized thrombus 
and recanalization (arrowheads). (F) The hepatic parenchyme is extinct (asterisk). (G) Venoportal cirrhosis. Portal tracts are seen within the fibrous septa 
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Figure 3. Microscopic findings of the large regenerative nodule. (A) A scanned image of the section reveals a well-demarcated solid mass with ir-
regular-shaped fibrous septa at the center of the nodule. The background liver is congested. (B) The nodule demonstrates “map-like” staining for 
glutamine synthetase. (C) Increased sinusoidal capillarization is seen in the nodule on immunohistochemical stain for CD34. (D, E) The central fi-
brous scar (D, asterisk) contains inflammatory cells, abundant ductular reaction, and abnormal vascular structures with eccentric vascular wall thick-
ening (E, arrowhead). (F) The hepatocyte plates are mildly thickened, showing 1-2 cell thickness with relatively increased N/C ratio. (A, D-F: hema-
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patic veins frequently demonstrated variable degrees of fibrous in-
timal thickening (Fig. 2). Sinusoidal congestion and hemorrhage 
was seen in the hepatic parenchyme predominantly in the centri-
lobular zones around the occluded hepatic veins, with marked si-
nusoidal dilatation, extravasation of erythrocytes into the spaces 
of Disse and atrophy of hepatocytes. The portal tracts and peri-
portal hepatocytes were relatively spared in some areas, resulting 
in a venocentric (reverse-lobulation) cirrhosis pattern. However, in 
other areas hepatic parenchymal extinction was seen also involv-
ing porto-periportal regions, and small/medium-sized portal veins 
were frequently occluded. Fibrous septa were seen bridging the 
portal tracts and hepatic veins, creating the venoportal cirrhosis 
pattern. No significant histological changes were seen in the large 
portal veins and hepatic arteries. Lobular and portal inflammation 
was mild, and there were no histological findings suggestive of 
autoimmune hepatitis.
Many regenerative nodules were seen across the entire liver, 
ranging from microscopic nodules to large regenerative nodules 
measuring up to 3.2 cm. The nodules were well-demarcated from 
the surrounding hepatic parenchyma. Six of the large regenerative 
nodules were FNH-like nodules, demonstrating irregular shaped 
fibrous scars at the center of the nodules, some resembling the 
typical stellate scars of FNH. The fibrous septa contained large 
vessels with irregularly thickened vascular walls, inflammatory 
cells and abundant ductular reaction (Fig. 3). The hepatocyte 
plates were mildly thickened up to 2-cell thickness. No significant 
cytological atypia was seen. A “map-like” glutamine synthetase 
expression pattern was seen in the FNH-like nodules. Glypican-3 
and heat shock protein 70 were not expressed in the nodules. 
CD34 immunostaining highlighted the increased sinusoidal capil-
larization in the nodules. 
DISCUSSION
Budd-Chiari syndrome is associated with a variety of histological 
patterns, depending on the duration of the obstruction, its severi-
ty, and the presence of portal vein obstruction, and as vascular 
occlusion is irregularly distributed in the liver, the histological find-
ings may vary in different areas of the same liver. The histological 
appearance of this condition in relation to the degree of hepatic 
and/or portal vein obstruction has been well summarized by Tana-
ka and Wanless.2 
Sinusoidal congestion is seen in the hepatic parenchyme to vari-
able degrees, with sinusoidal dilatation and atrophy of hepato-
cytes. The spaces of Disse may be infiltrated by erythrocytes in 
more severe lesions, with hemorrhage in the liver cell plates, and 
necrosis of hepatocytes and endothelial cells. Contiguous loss of 
hepatocytes with approximation of portal and hepatic vein regions 
may ensue, resulting in parenchymal extinction. The pattern of fi-
brosis in Budd-Chiari syndrome may be veno-centric, veno-portal 
or mixed veno-centric/veno-portal, and the type of fibrosis present 
depends on the presence and severity of hepatic vein and/or por-
tal vein obstruction. The obstructing thrombus may be an acute 
thrombus with fresh hemorrhage, or appear as inflamed granula-
tion tissue with fibrosis and recanalization. If only the hepatic 
veins are occluded, hepatocellular regeneration may occur around 
patent portal veins; small hepatic veins are incorporated into and 
connected by fibrous septa, creating a veno-centric type of cirrho-
sis. Portal tracts are seen at the center of the cirrhotic nodules. 
Secondary portal vein occlusion is frequently seen in Budd-Chiari 
syndrome; this results in the extinction of periportal parenchyme 
and porto-central-portal bridging (veno-portal cirrhosis). Portal 
tracts can be recognized in the fibrous septa, and the cirrhotic 
nodules do not contain portal tracts. Both patterns of cirrhosis are 
frequently seen (mixed veno-centric/veno-portal) especially in ex-
planted livers as the degree and type of vascular occlusion is irreg-
ularly distributed in the liver. 
Large regenerative nodules have been found in the majority of 
livers with Budd-Chiari syndrome, and are considered to represent 
a reactive rather than neoplastic hepatocellular proliferation.2-4 
The vascular dynamics of these nodules have been shown to be 
different from the surrounding parenchyma: large regenerative 
nodules are characterized by an absence of portal veins and prom-
inent arteries that branch to supply the entire nodule with arterial 
blood. Drainage is into the hepatic veins which are usually patent 
in these regions. Some large regenerative nodules have central 
stellate scars, resulting in an appearance indistinguishable from 
FNH.2-4 
Large regenerative nodules, including FNH-like nodules, should 
be distinguished from hepatocellular neoplasms such as hepato-
cellular carcinoma; hepatocellular carcinomas have indeed been 
reported in livers with Budd-Chiari syndrome. Glutamine synthe-
tase immunohistochemistry is being increasingly used in diagnos-
tic practice, either as a part of a panel of markers – along with 
glypican-3 and heat shock protein 70 – for the diagnosis of hepa-
tocellular carcinoma, or for the diagnosis of FNH in which a char-
acteristic “map-like” staining pattern has been recognized.5,6 Glu-
tamine synthetase is typically expressed in the hepatocytes around 
the central vein, due to β-catenin activation in the perivenular re-
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gion, and the expansion of β-catenin-activated centrizonal region 
in FNH has been presumed to result in the “map-like” overexpres-
sion of glutamine synthetase. Although this pattern of staining 
has not been recognized in FNH-like nodules in cirrhotic livers, 
suggesting that FNH and FNH-like nodules in cirrhosis have differ-
ent pathophysiological origins, it is possible that FNH-like nodules 
associated with vascular lesions such as Budd-Chiari syndrome 
and hereditary hemorrhagic telangiectasia may have pathophysio-
logical similarities to FNH.7,8 While glutamine synthetase expres-
sion with a “map-like” pattern was seen in our case, glypican-3 
and heat shock protein 70 were negative in the nodules, and to-
gether with the histological findings (no significant cytological or 
architectural atypia) the diagnosis of well-differentiated hepato-
cellular carcinoma could be excluded. 
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